ABCA7
Basic information
Region (hg38): 19:1039997-1065572
Links
Phenotypes
GenCC
Source:
- Alzheimer disease 9 (Limited), mode of inheritance: Unknown
ClinVar
This is a list of variants' phenotypes submitted to
- ABCA7-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ABCA7 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 33 | 42 | ||||
missense | 159 | 26 | 14 | 199 | ||
nonsense | 4 | |||||
start loss | 0 | |||||
frameshift | 11 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 7 | |||||
splice region | 6 | 4 | 10 | |||
non coding | 9 | |||||
Total | 1 | 13 | 166 | 63 | 29 |
Highest pathogenic variant AF is 0.00000657
Variants in ABCA7
This is a list of pathogenic ClinVar variants found in the ABCA7 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-1041353-A-G | ABCA7-related disorder | Benign (Mar 29, 2019) | ||
19-1041388-G-A | Likely benign (Oct 01, 2022) | |||
19-1041416-C-T | not specified | Uncertain significance (Aug 09, 2021) | ||
19-1041541-T-C | Likely benign (Feb 16, 2018) | |||
19-1041613-C-G | Likely benign (Dec 14, 2018) | |||
19-1041829-A-T | Alzheimer disease 9 | Uncertain significance (-) | ||
19-1041910-C-T | Likely benign (Jul 21, 2018) | |||
19-1041940-GC-G | Likely pathogenic (Mar 24, 2022) | |||
19-1041972-T-G | Amyotrophic lateral sclerosis | Uncertain significance (Nov 10, 2022) | ||
19-1042060-C-G | Likely benign (Jul 20, 2018) | |||
19-1042079-A-G | Likely benign (Apr 23, 2018) | |||
19-1042354-C-T | ABCA7-related disorder | Benign (Apr 03, 2018) | ||
19-1042394-C-T | Likely benign (Feb 26, 2018) | |||
19-1042748-A-G | ABCA7-related disorder | Benign (Jun 28, 2019) | ||
19-1042810-A-G | Benign (Aug 22, 2019) | |||
19-1042831-G-A | Likely benign (Dec 31, 2019) | |||
19-1043048-C-T | not specified | Uncertain significance (Jun 23, 2021) | ||
19-1043053-C-T | Likely benign (Dec 07, 2019) | |||
19-1043140-G-A | Uncertain significance (Nov 03, 2021) | |||
19-1043153-G-A | not specified | Uncertain significance (Mar 11, 2024) | ||
19-1043162-T-G | not specified | Likely benign (Jan 03, 2024) | ||
19-1043178-C-A | not specified | Uncertain significance (Mar 12, 2024) | ||
19-1043184-C-T | Benign (Dec 31, 2019) | |||
19-1043194-G-T | not specified | Uncertain significance (Jan 10, 2023) | ||
19-1043197-C-G | not specified | Uncertain significance (Jan 17, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ABCA7 | protein_coding | protein_coding | ENST00000263094 | 46 | 25470 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.11e-55 | 5.07e-7 | 124312 | 2 | 1434 | 125748 | 0.00573 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.47 | 1516 | 1.36e+3 | 1.11 | 0.0000934 | 13509 |
Missense in Polyphen | 521 | 481.43 | 1.0822 | 5228 | ||
Synonymous | -1.07 | 649 | 615 | 1.05 | 0.0000438 | 4708 |
Loss of Function | 0.973 | 90 | 101 | 0.895 | 0.00000513 | 1043 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0214 | 0.0204 |
Ashkenazi Jewish | 0.00929 | 0.00867 |
East Asian | 0.00723 | 0.00693 |
Finnish | 0.00343 | 0.00199 |
European (Non-Finnish) | 0.00580 | 0.00518 |
Middle Eastern | 0.00723 | 0.00693 |
South Asian | 0.00428 | 0.00406 |
Other | 0.00599 | 0.00539 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role in phagocytosis by macrophages of apoptotic cells. Binds APOA1 and may function in apolipoprotein-mediated phospholipid efflux from cells. May also mediate cholesterol efflux. May regulate cellular ceramide homeostasis during keratinocytes differentiation. {ECO:0000269|PubMed:12917409, ECO:0000269|PubMed:12925201, ECO:0000269|PubMed:14570867, ECO:0000269|PubMed:14592415}.;
- Disease
- DISEASE: Alzheimer disease 9 (AD9) [MIM:608907]: A familial, late- onset form of Alzheimer disease. Alzheimer disease is a neurodegenerative disorder characterized by progressive dementia, loss of cognitive abilities, and deposition of fibrillar amyloid proteins as intraneuronal neurofibrillary tangles, extracellular amyloid plaques and vascular amyloid deposits. The major constituents of these plaques are neurotoxic amyloid-beta protein 40 and amyloid-beta protein 42, that are produced by the proteolysis of the transmembrane APP protein. The cytotoxic C- terminal fragments (CTFs) and the caspase-cleaved products, such as C31, are also implicated in neuronal death. {ECO:0000269|PubMed:25807283, ECO:0000269|PubMed:26141617}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
- Pathway
- ABC transporters - Homo sapiens (human);ABC transporters in lipid homeostasis;Transport of small molecules;ABC-family proteins mediated transport
(Consensus)
Recessive Scores
- pRec
- 0.155
Intolerance Scores
- loftool
- 0.0339
- rvis_EVS
- -2.15
- rvis_percentile_EVS
- 1.46
Haploinsufficiency Scores
- pHI
- 0.0555
- hipred
- N
- hipred_score
- 0.144
- ghis
- 0.520
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.392
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Abca7
- Phenotype
- adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); renal/urinary system phenotype;
Gene ontology
- Biological process
- lipid transport;phagocytosis;memory;positive regulation of cholesterol efflux;peptide cross-linking;cholesterol efflux;phospholipid efflux;high-density lipoprotein particle assembly;protein localization to nucleus;apolipoprotein A-I-mediated signaling pathway;negative regulation of amyloid precursor protein biosynthetic process;phospholipid translocation;positive regulation of phagocytosis;transmembrane transport;positive regulation of ERK1 and ERK2 cascade;positive regulation of amyloid-beta clearance;positive regulation of engulfment of apoptotic cell;negative regulation of amyloid-beta formation;positive regulation of phospholipid efflux
- Cellular component
- Golgi membrane;phagocytic cup;Golgi apparatus;plasma membrane;cell surface;integral component of membrane;cell junction;early endosome membrane;ruffle membrane;ATP-binding cassette (ABC) transporter complex;intracellular membrane-bounded organelle
- Molecular function
- transporter activity;lipid transporter activity;protein binding;ATP binding;ATPase activity;apolipoprotein A-I receptor activity;ATPase activity, coupled to transmembrane movement of substances;phosphatidylcholine-translocating ATPase activity;phosphatidylserine-translocating ATPase activity